GALEAS™ Oncology Panels

This comprehensive solution for tissue and liquid biopsies combines the Cell3™ Target NGS technology-based target panel with our proprietary analysis pipeline. It enables early and accurate cancer detection. Designed to detect low-frequency mutations, it supports precise patient monitoring and informed treatment decision-making in cancer research and clinical practice.

Cell3™ Target: Custom Panel

Cell3™ Target is a high-precision NGS target panel validated in various types of DNA samples, including cfDNA, gDNA, and FFPE DNA.

To ensure uniform coverage, we implement strict quality control (QC) measures and utilize error suppression technology, enabling accurate detection of minor variants down to an allele frequency (VAF) of 0.1%.

With our free panel design tool, you can easily and quickly create custom panels, targeting anywhere from 1 to 1,000 genes based on information such as BED files, gene lists, and specific genomic coordinates. Cell3™ Target features industry-leading integrated algorithms that automatically mask repetitive regions and fill design gaps, ensuring efficient and uniform coverage of target areas.

Germline

The NGS target panel designed using Cell3™ Target technology accurately detects chromosomal abnormalities, including SNVs, indels, and CNVs.

Traditional methods for assessing germline variants often require multiple tests, such as FISH, karyotyping, MLPA, and microarray. Our NGS-based solution integrates these workflows, allowing for the analysis of SNVs, indels, and CNVs in a single assay, significantly saving time and resources.